These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

318 related items for PubMed ID: 8701190

  • 21. [Neuroendocrine activation in heart failure I. Pathophysiology and pharmacological intervention].
    Kjaer A.
    Ugeskr Laeger; 2000 Oct 30; 162(44):5905-9. PubMed ID: 11094549
    [Abstract] [Full Text] [Related]

  • 22. Interaction between the adrenergic and renin-angiotensin-aldosterone-systems.
    van Zwieten PA, de Jonge A.
    Postgrad Med J; 1986 Oct 30; 62 Suppl 1():23-7. PubMed ID: 3534860
    [Abstract] [Full Text] [Related]

  • 23. Vascular protection: current possibilities and future perspectives.
    Lüscher TF.
    Int J Clin Pract Suppl; 2001 Jan 30; (117):3-6. PubMed ID: 11715356
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Sodium and water retention in heart failure: pathogenesis and treatment.
    Martin PY, Schrier RW.
    Kidney Int Suppl; 1997 Jun 30; 59():S57-61. PubMed ID: 9185106
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Endothelial dysfunction in human disease.
    Drexler H, Hornig B.
    J Mol Cell Cardiol; 1999 Jan 30; 31(1):51-60. PubMed ID: 10072715
    [Abstract] [Full Text] [Related]

  • 30. Endothelial function in patients with chronic heart failure.
    Elkayam U, Prakash M, Subbiah S, Mehdi S, Nikitina A, Akhter W.
    J Cardiovasc Pharmacol; 2001 Nov 30; 38 Suppl 2():S47-8. PubMed ID: 11811377
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. [Endothelial function in coronary atherosclerosis and heart failure--the role of nitric oxide in regulation of vasomotor tone].
    Andreassen AK, Kirkebøen KA.
    Tidsskr Nor Laegeforen; 1999 Nov 10; 119(27):4066-9. PubMed ID: 10613099
    [Abstract] [Full Text] [Related]

  • 34. Baroreceptor function in congestive heart failure: effect on neurohumoral activation and regional vascular resistance.
    Hirsch AT, Dzau VJ, Creager MA.
    Circulation; 1987 May 10; 75(5 Pt 2):IV36-48. PubMed ID: 2882866
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Interaction between nitric oxide and the cholinergic and sympathetic nervous system in cardiovascular control in humans.
    Sartori C, Lepori M, Scherrer U.
    Pharmacol Ther; 2005 May 10; 106(2):209-20. PubMed ID: 15866320
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.